An Insight into the Psyche of Patients with Oral Sub Mucous Fibrosis: A Cross Secional Study of 580 Cases

Main Article Content

Hitesh Vadera
Deval Mehta
Ramita Sood
Divya Jain

Abstract

580 diagnosed cases of OSMF were classified into various grades using a standardised classification system and evaluated for depression, stress and anxiety using the DASS 42 questionnaire. Patients with grade 1 OSMF were found to be undergoing mild depression, mild anxiety and severe stress. The interpretation for grade 4 OSMF patients showed that they were suffering from severe depression, extremely severe anxiety and moderate stress. All these 3 psychological conditions, if present together have a hazardous impact on the systemic health of the individual and therefore the treatment of OSMF should consist of psychological and / or psychiatric intervention as well.

Article Details

How to Cite
Hitesh Vadera, Deval Mehta, Ramita Sood, & Divya Jain. (2023). An Insight into the Psyche of Patients with Oral Sub Mucous Fibrosis: A Cross Secional Study of 580 Cases. Journal of Coastal Life Medicine, 11(1), 3150–3156. Retrieved from https://www.jclmm.com/index.php/journal/article/view/821
Section
Articles

References

Aishwarya, K. M., Reddy, M. P., Kulkarni, S., Doshi, D., Reddy, B. S., & Satyanarayana, D. (2017, August 27). Effect of frequency and duration of tobacco use on oral mucosal lesions – A cross-sectional study among tobacco users in Hyderabad, India. Asian Pacific Journal of Cancer Prevention: APJCP, 18(8), 2233–2238. Https://doi.org/10.22034/APJCP.2017.18.8.2233. (n.d.).

Angadi, P. V., & Rekha, K. P. (2010). Oral submucous fibrosis: A clinicopathologic review of 205 cases in Indians. Oral and Maxillofacial Surgery, 15(1), 15–19. Doi:10.1007/s10006-010-0225-x. (n.d.).

Ansari, Z. A., Bano, S. N., & Zulkifle, M. (2010, January). Prevalence of tobacco use among power loom workers – A cross-sectional study. Indian Journal of Community Medicine, 35(1), 34–39. Https://doi.org/10.4103/0970-0218.62551. (n.d.).

Barbee, J. G. (1998). Mixed symptoms and syndromes of anxiety and depression: Diagnostic, prognostic, and etiologic issues. Annals of Clinical Psychiatry, 10(1), 15-29. (n.d.).

Cox, S. C., & Walker, D. M. (1996). Oral submucous fibrosis. A review. Australian Dental Journal;, 41(5):, 294–299. Https://doi.org/10.1111/j.1834-7819.1996.tb03136.x. (n.d.).

Gupta PC, Warnakulasuriya S. (2002) Global epidemiology of areca nut usage. Addict Biol;7(1):77–83. (n.d.).

Hosein, M., Mohiuddin, S., & Fatima, N. (2015). Association Between Grading of Oral Submucous Fibrosis With Frequency and Consumption of Areca Nut and Its Derivatives in a Wide Age Group: A Multi-centric Cross Sectional Study From Karachi, Pakistan. Journal of cancer prevention, 20(3), 216–222. Https://doi.org/10.15430/JCP.2015.20.3.216. (n.d.).

Kanodia, S., Giri, V. P., Giri, O. P., Devi, M. P., & Garima, Y. (2017). Assessment of anxiety, depression, and serum cortisol level in oral submucous fibrosis patients: A controlled clinical trial. European journal of dentistry, 11(3), 293–298. Https://doi.org/10.4103/ejd.ejd_9_17. (n.d.).

Lovibond, S.H., Lovibond, P.F. (1995). Manual for the Depression Anxiety Stress Scales (2nd ed.). Sydney: Psychology Foundation. (n.d.).

More, C. B., & Rao, N. R. (2019). Proposed clinical definition for oral submucous fibrosis. Journal of Oral Biology and Craniofacial Res.earch;, 9(4):, 311–314. Https://doi.org/10.1016/j.jobcr.2019.06.016. (n.d.).

More, C. B., Rao, N. R., More, S., & Johnson, N. W. (2020). Reasons for initiation of areca nut and related products in patients with oral submucous fibrosis within an endemic area in Gujarat, India. Substance Use and Misuse, 55(9), 1413–1421. Https://doi.org/10.1080/10826084.2019.1660678. (n.d.).

More C, Gupta S, Joshi J, Varma S. (2012)Classification system of Oral submucous fibrosis. J Indian Acad Oral Med Radiol,24(1), 24–9. (n.d.).

More, C., Peter, R., Nishma, G., Chen, Y., & Rao, N. (2018). Association of Candida species with Oral submucous fibrosis and Oral leukoplakia: A case control study. Annals of Clinical and Laboratory Res.earch; 06(3):, 248. Https://doi.org/10.21767/2386-5180.100248. (n.d.).

More C, Shilu K, Gavli N, Rao NR. (2018)Etiopathogenesis and clinical manifestations of oral submucous fibrosis, a potentially malignant disorder: An update. Int J Curr Res;10(07):71816–20. (n.d.).

Murugan, S. M. (2021). Assessment of incidence of oral submucous fibrosis patients – An institutional study. International Journal of Dentistry and Oral Science, 1939–1945. Https://doi.org/10.19070/2377-8075-21000384. (n.d.).

Prince M, Patel V, Saxena S, Maj M, Maselko J, Phillips MR, et al. (2007) No health without mental health. Lancet. 370,p859–77. (n.d.).

Ramsey, M. W., Jr, Chen-Sankey, J. C., Reese-Smith, J., & Choi, K. (2019). Association between marital status and cigarette smoking: Variation by race and ethnicity. Preventive medicine, 119, 48–51. Https://doi.org/10.1016/j.ypmed.2018.12.010. (n.d.).

Rao, N. R., Villa, A., More, C. B., Jayasinghe, R. D., Kerr, A. R., & Johnson, N. W.. (2020). Oral submucous fibrosis: AA contemporary narrative review with a proposed inter-professional approach for an early diagnosis and clinical management. Journal of Otolaryngology -– Head and Neck Surg.ery; December;, 49(1):, 3. Https://doi.org/10.1186/s40463-020-0399-7. (n.d.).

Saalim, M., Sansare, K., Karjodkar, F. R., Ali, I. K., Sharma, S. R., Kapoor, R., Mehra, A., & Rahman, B. (2022). Oral submucous fibrosis and its impact on psychological stress: A case-control study. Psychology, Health & Medicine, 27(4), 735–745. https://doi.org/10.1080/13548506.2020.1826545

Saraceno B, van Ommeren M, Batniji R, Cohen A, Gureje O, Mahoney J, et al. (2007)Barriers to improvement of mental health services in low-income and middle-income countries. Lancet. 370, p1164–74. (n.d.).

Sekhon, S., & Gupta, V. (updated 2022, May 8). Mood Disorders. In: StatPearls [Internet]. (2022, January)-. Available from. Https://www.ncbi.nlm.nih.gov/books/NBK558911/. StatPearls Publishing. (n.d.).

Smith, K. Mental health: A world of depression.(2014) Nature 515, p180–181. (n.d.).

Srinivasan M, Jewell SD.(2001) Evaluation of TGF-alpha and EGFR expression in oral leukoplakia and oral submucous fibrosis by quantitative immunohistochemistry. Oncol;61(4):284–92. (n.d.).

Tariq, H., Ahmed, S., Naz, M., & Naureen, A. (2020). Frequency of oral sub mucous fibrosis and its correlation with the level of education in patients coming to a tertiary care hospital of Karachi from January 2018 to December 2018. Asian Pacific Journal of Cancer Care, 5(3), 157–160. Https://doi.org/10.31557/apjcc.2020.5.3.157-160. (n.d.).

Thakur, N., & Kumar, V. (2014). An outline of existing clinical classification system for oral submucous fibrosis. Research Advances Dent, 3(2), 72–75. (n.d.).

Xie, H., Li, C., He, Y., Griffin, R., Ye, Q., & Li, L. (2015). Chronic stress promotes oral cancer growth and angiogenesis with increased circulating catecholamine and glucocorticoid levels in a mouse model. Oral oncology, 51(11), 991–997. Https://doi.org/10.1016/j.oraloncology.2015.08.007. (n.d.).

Yuan, L., Pan, B., Wang, W., Wang, L., Zhang, X., & Gao, Y. (2020). Prevalence and predictors of anxiety and depressive symptoms among patients diagnosed with oral cancer in China: A cross-sectional study. BMC Psychiatry, 20(1), 394. Https://doi.org/10.1186/s12888-020-02796-6. (n.d.).